CARLOS
TAXONERA SAMSO
Profesor asociado de Ciencias de la Salud
![Foto de CARLOS](/img/nophoto.png)
![Foto de Hospital Universitario de Valme](/img/noimage_org.png)
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (5)
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2017
-
Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial
Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1293-1301
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131
2009
-
Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing crohn's disease
Journal of Clinical Gastroenterology, Vol. 43, Núm. 10, pp. 950-956